Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary - Institute of Medicine

•The newest report “Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary” based on the November 2010 workshop from the Institute of Medicine’s Roundtable on Translating Genomic-Based Research for Health has been released.

Ten years after the sequencing of the human genome, scientists have developed genetic tests that can predict a person’s response to certain drugs, estimate the risk of developing Alzheimer’s disease, and make other predictions based on known links between genes and diseases. However, most clinical practitioners do not use these tests regularly, and genetic testing has yet to become part of routine medical care. One barrier is the lack of evidence for their effectiveness—there is little to show that using these tests improves patients’ health.

The IOM’s Roundtable on Translating Genomic-Based Research for Health held a workshop on November 17, 2010, to explore barriers and solutions to generating evidence for genetic tests. Participants discussed stakeholder views on the use of evidence in decision-making processes such as clearance, reimbursement, clinical practice adoption, and patient utility; innovative methods to generate high-quality evidence more efficiently; and potential ways to overcome current limitations in generating evidence of clinical utility. This document summarizes the workshop.

Roundtable on Translating Genomic-Based Research for Health - Institute of Medicine
Roundtable on Translating Genomic-Based Research for Health - Institute of Medicine

open here please:
--------------
Generating Evidence for Genomic Diagnostic Test Development – Workshop Summary - Institute of Medicine